These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Mehra V; Brennan PJ; Rada E; Convit J; Bloom BR Nature; 1984 Mar 8-14; 308(5955):194-6. PubMed ID: 6366573 [TBL] [Abstract][Full Text] [Related]
3. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597 [TBL] [Abstract][Full Text] [Related]
4. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients. Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851 [TBL] [Abstract][Full Text] [Related]
5. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components. Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369 [TBL] [Abstract][Full Text] [Related]
6. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy. Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278 [TBL] [Abstract][Full Text] [Related]
7. The immunobiology of leprosy. Kaplan G; Cohn ZA Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911 [TBL] [Abstract][Full Text] [Related]
8. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780 [TBL] [Abstract][Full Text] [Related]
9. An analysis of in vitro T cell responsiveness in lepromatous leprosy. Kaplan G; Weinstein DE; Steinman RM; Levis WR; Elvers U; Patarroyo ME; Cohn ZA J Exp Med; 1985 Sep; 162(3):917-29. PubMed ID: 3928804 [TBL] [Abstract][Full Text] [Related]
10. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens. Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115 [TBL] [Abstract][Full Text] [Related]
11. Reversal by interleukin-2 of the T cell unresponsiveness of lepromatous leprosy to Mycobacterium leprae. Haregewoin A; Mustafa AS; Helle I; Waters MF; Leiker DL; Godal T Immunol Rev; 1984 Aug; 80():77-86. PubMed ID: 6386665 [TBL] [Abstract][Full Text] [Related]
12. Suppressor T lymphocytes from lepromatous leprosy skin lesions. Modlin RL; Mehra V; Wong L; Fujimiya Y; Chang WC; Horwitz DA; Bloom BR; Rea TH; Pattengale PK J Immunol; 1986 Nov; 137(9):2831-4. PubMed ID: 2944966 [TBL] [Abstract][Full Text] [Related]
13. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants. Reitan LJ; Closs O; Belehu A Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003 [TBL] [Abstract][Full Text] [Related]
14. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. Kaplan G; Gandhi RR; Weinstein DE; Levis WR; Patarroyo ME; Brennan PJ; Cohn ZA J Immunol; 1987 May; 138(9):3028-34. PubMed ID: 3106496 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of cell mediated immunity in the histopathologic spectrum of leprosy using lymphocyte transformation test. Job CK; Chacko CJ; Taylor PM; Daniel M; Jesudian G Int J Lepr Other Mycobact Dis; 1976; 44(1-2):256-66. PubMed ID: 776862 [TBL] [Abstract][Full Text] [Related]
16. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy. Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953 [TBL] [Abstract][Full Text] [Related]
17. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. Mustafa AS Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259 [TBL] [Abstract][Full Text] [Related]
18. Vaccine development. On relating immunology to the Third World: some studies on leprosy. Bloom BR; Salgame P; Mehra V; Kato H; Modlin R; Rea T; Brennan P; Convit J; Lugozi L; Snapper S Immunol Suppl; 1989; 2():87-9; discussion 91-2. PubMed ID: 2680926 [TBL] [Abstract][Full Text] [Related]
19. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae. Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193 [TBL] [Abstract][Full Text] [Related]
20. Immunosuppression and cellular immunity reactions in leprosy patients treated with a mixture of Mycobacterium leprae and BCG. Rada EM; Convit J; Ulrich M; Gallinotto ME; Aranzazu N Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):646-50. PubMed ID: 2963084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]